世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

人工知能(AI)技術市場予測 2018年:産業調査の専門家パネルの見解

Artificial Intelligence Technologies: Market Prospects – Featuring Expert Panel Views from Industry Survey 2018

 

出版社 出版年月ファイ ル/CD-ROM価格 ページ数図表数
CBR Pharma Insights
CBRファーマインサイツ
2018年3月US$2,995
シングルユーザライセンス(PDF)
105 50

サマリー

Description

GBI Research’s latest report: “Artificial Intelligence Technologies: Market Prospects – Featuring Expert Panel Views From Industry Survey 2018” considers the current and future impact of artificial intelligence (AI) technologies within the pharmaceutical and healthcare sectors. AI is defined as the theoretical and practical application of computer systems able to perform tasks usually requiring human intelligence such as visual perception, learning, decision making and translation between languages. The healthcare and pharmaceutical sectors are among the pioneers of AI adoption and development within industry as a whole. This is driven by the need to reduce research and development (R&D) costs, and to meet consumer demand for effective medical interventions at a reasonable price. This report features an overview of AI technologies, with a focus on how these technologies will impact the pharmaceutical and healthcare industry. It examines factors driving the use of AI in R&D, and provides detailed examples of how different platforms and services can provide direct benefits to both the healthcare industries and consumers using them. GBI Research conducted a targeted industry survey of experts and key opinion leaders in the AI field to gather insight and opinions on the current trends and future commercial prospects of the use of AI within the healthcare and pharmaceutical sectors. The survey explored a wide range of strategic topics in the field, including key market drivers and restraints, and the most common areas where the AI technologies are being applied within the pharmaceutical pipeline development chain, prospects for future investments in AI, important factors to consider when implementing AI in industry, and other important areas for current and future investors in AI. The report also provides an analysis of the main challenges surrounding the adoption of AI technologies within the healthcare and pharmaceutical industries. AI developers and investors in the market will still need to address significant barriers to achieve higher adoption rates in the market. Mitigating risks and concerns regarding data security and privacy will be crucial. Other important restraints identified in this report include the currently unclear regulatory and legal frameworks surrounding AI, and the shortage of skilled IT professional in the healthcare industry. Despite the aforementioned barriers to the further expansion of the AI market, growing investment in AI and digital pharmaceutical developments represent encouraging trends.

Scope

  • How prevalent is the usage of AI technologies within the healthcare and pharmaceutical sectors and how will this change in the coming years?

  • What are the most important drivers and restraints of AI adoption within healthcare and pharmaceuticals?

  • What are the key stakeholders in the funding and provision of AI technologies within healthcare and pharmaceuticals?

  • How will different sectors, such as clinical trials, diagnostics and epidemiological forecasting be impacted by AI technologies?

Reasons To Buy

  • Develop a comprehensive understanding of AI technologies and their applications within the healthcare and pharmaceutical sectors

  • Gain insight into the key players within the industry, including multi-national technology firms and AI start-up firms, with case studies and company profiles

  • Analyze trends within the AI strategic consolidations landscape

  • Gain insights from industry experts on the current status and future prospects for AI within healthcare and pharmaceuticals (GBI Research’s survey comprises responses from 105 organizations)



目次

1 Table of Contents 4

1.1 List of Tables 7

1.2 List of Figures 7

2 Overview of Artificial Intelligence Technologies 9

2.1 Current and Future Value of Global Artificial Intelligence Market 9

2.2 What is Artificial Intelligence? 9

2.2.1 Machine Learning 10

2.2.2 Algorithms 13

2.2.3 Data Sharing Platforms 14

2.2.4 Future Considerations 14

3 Artificial Intelligence in the Healthcare and Pharmaceutical Industries 15

3.1 Overview of Artificial Intelligence in the Pharmaceutical and Healthcare Industries 15

3.2 Services Benefitting From Artificial Intelligence Technologies within the Healthcare and Pharmamceutical Sectors 16

3.3 Key Objectives of Artificial Intelligence Technologies within Healthcare and Pharmaceuticals? 16

3.4 Key Stakeholders in the Funding and Provision of Artificial Intelligence Technologies 18

3.4.1 Payers 18

3.4.2 Financial intermediaries 19

3.4.3 Providers 19

3.4.4 Purchasers 19

3.4.5 Producers 19

3.4.6 Information Technology 19

3.5 Key Market Segments 19

3.5.1 Artificial Intelligence Technology Companies 20

3.5.2 Pharmaceutical and Medical Devices Industries 20

3.5.3 Healthcare Professionals 21

3.6 How Prevalent is the Use of AI Technology by Healthcare Organizations? Industry Survey Results 22

4 Key Drivers and Restraints for Artificial Intelligence within the Healthcare and Pharmaceutical Sectors 24

4.1 Key Drivers in the Global Artificial Intelligence Healthcare and Pharmaceutical Markets – Industry Survey Results 24

4.1.1 Need for More Cost-Effective Methods in Drug Development and R&D 25

4.1.2 Increased Need to Demonstrate Value and Effectiveness of Therapies 26

4.1.3 Unmet Clinical Needs that Conventional Approaches Failed to Address 27

4.1.4 Increasing Processing Power and Decreasing Costs Associated with Artificial Intelligence Technology 28

4.1.5 Increasing Demand for Products and Services Due to an Ageing Population 29

4.1.6 Increased Need to Reduce the Imbalance between Healthcare Services and Patient Demand 29

4.1.7 Increased Need for Cross-Sector Partnerships 30

4.1.8 Other Important Growth Drivers in the Artificial Intelligence Market in 2018 31

4.2 Key Restraints in the Global Artificial Intelligence Healthcare and Pharmaceutical Markets – Industry Survey Results 32

4.2.1 Concerns Regarding Data Security and Privacy 33

4.2.2 Reluctance of Healthcare Practitioners to Adopt New Technologies 34

4.2.3 Unclear Regulatory and Legal Frameworks Surrounding the Use of Artificial Intelligence 35

4.2.4 Lack of Curated Healthcare Data and Associated Infrastructure 36

4.2.5 Shortage of IT Skills within the Healthcare Industry 36

4.2.6 Difficulty in Deployment of Artificial Intelligence Technologies 37

4.2.7 High Initial Capital Requirement 37

4.2.8 Patented Artificial Intelligence Technologies 38

5 Opportunities for Artificial Intelligence within the Healthcare and Pharmaceutical Industries 39

5.1 Current Roles of Artificial Intelligence in the Pharmaceutical and Healthcare Industries 39

5.2 Artificial Intelligence Opportunities in the Pharmaceutical Industry 41

5.2.1 Artificial Intelligence in Drug Discovery and Preclinical Development 42

5.2.2 Artificial Intelligence in Clinical Trials: Optimizing Study Design and Patient Recruitment 45

5.2.3 Opportunities for Artificial Intelligence beyond R&D: Pharmacovigilance, Manufacturing and Marketing 48

5.2.4 Concluding Remarks: Artificial Intelligence Benefits from Discovery to Marketing 50

5.3 Artificial Intelligence Opportunities in the Healthcare Industry 51

5.3.1 Personalized Medicine, Monitoring & Management 52

5.3.2 Diagnostics 54

5.3.3 Epidemiological Forecasting 56

5.3.4 Big Data 57

5.3.5 Concluding Remarks – Big Data May decide the Future of the Industry 57

6 Key Players and Strategic Consolidations within the Artificial Intelligence Healthcare and Pharmaceutial Landscape 59

6.1 Strategic Consolidations Landscape 59

6.1.1 Investment and Partnerships 59

6.1.2 Co-development deals 59

6.1.3 Licensing Deals 64

6.1.4 Investors 65

6.2 The Company Landscape 65

6.2.1 Large Pharmaceutical Companies 65

6.2.2 Large Technology Firms with Vested Healthcare Interests 69

6.2.3 Artificial Intelligence Start-ups 71

7 Conclusions and Future Outlook for AI Technologies 79

7.1 The Greatest Positive Impact will be Seen In Personalized Medicine in the Next Five Years 80

7.2 Some 69% of Survey Respondents are Likely to Increase their Investments within Artificial Intelligence Technologies in the Next Five Years 81

7.3 Which Regions Will Receive the Highest Investments in Artificial Intelligence in the Next Five Years? Industry Survey Results 82

7.4 What Are the Main Concerns for Companies Looking to Invest in Artificial Intelligence? Industry Survey Results 83

7.5 What Are the Regional Concerns for Companies Looking to Invest in Artificial Intelligence? Industry Survey Results 84

8 Appendix 86

8.1 GBI Industry Survey: Breakdown of Respondents by Industry 86

8.2 GBI Industry Survey: Breakdown of Respondents by Region 86

8.3 GBI Industry Survey: Proportion of Organizations that are Currently Involved with Artificial Intelligence Technologies 87

8.4 GBI Industry Survey: Most Important Factors Driving Growth in the Artificial Intelligence Market 87

8.5 GBI Industry Survey: Main Factors Restraining Growth in the Artificial Intelligence Market 88

8.6 GBI Industry Survey: Main Concerns for Organizations When Investing in Artificial Intelligence Technologies 88

8.7 GBI Industry Survey: Most Common Areas Where Artificial Intelligence Solutions are Used in the Pharmaceutical Industry 89

8.8 GBI Industry Survey: Most Common Areas Where Artificial Intelligence Solutions are Used in the Healthcare Industry 89

8.9 GBI Industry Survey: Areas of the Pharmaceutical Industry That Will See the Greatest Benefits From Artificial Intelligence Implementation 90

8.10 GBI Industry Survey: Areas of the Healthcare Industry That Will See the Greatest Benefit from Artificial Intelligence Implementation 90

8.11 GBI Industry Survey: The Area in which AI Technology Will Have the Greatest Positive Impact in the Healthcare Landscape Over the Next Five Years 91

8.12 GBI Industry Survey: Likelihood of Organizations Involved with Artificial Intelligence Increasing Investments in the Sector (%), 2018-2023 91

8.13 GBI Industry Survey: Likelihood of Organizations Involved with Artificial Intelligence Increasing Investments in the Sector (%), 2018-2023, North American Panel vs. European Panel vs. Asian Panel 92

8.14 GBI Industry Survey: Main Concerns for Organizations When Investing in Artificial Intelligence Technologies, North American Panel vs. European Panel vs. Asian Panel 92

8.15 References 93

8.16 Abbreviations List 104

8.17 Report Methodology 105

8.18 About GBI Research 105

 

List of Figures

Figure 1: Artificial Intelligence Technologies, Main Divisions and Examples of Artificial Intelligence, 2018 10

Figure 2: Artificial Intelligence Technologies, Applications of Artificial Intelligence in the Healthcare Space, 2018 15

Figure 3: Artificial Intelligence Technologies, Key Stakeholders in the Provision of Funding to Drive Artificial Intelligence in Healthcare, 2018 18

Figure 4: Artificial Intelligence Technologies, Key Market Segments in the Artificial Intelligence Market Space, 2018 20

Figure 5: Artificial Intelligence Technologies, GBI Research Industry Survey, Breakdown of Respondents by Industry, 2018 22

Figure 6: Artificial Intelligence Technologies, Breakdown of Respondents by Region, 2018 23

Figure 7: Artificial Intelligence Technologies, GBI Research Industry Survey, Proportion of Respondents Currently Involved with Artificial Intelligence, 2018 23

Figure 8: Artificial Intelligence Technologies, GBI Research Industry Survey, Most Important Factors Driving Growth in the Artificial Intelligence Healthcare and Pharmaceutical Markets, 2018 24

Figure 9: Artificial Intelligence, GBI Research Industry Survey, Most Important Factors Restraining Growth in the Artificial Intelligence Healthcare and Pharmaceutical Markets, 2018 32

Figure 10: Artificial Intelligence Technologies, GBI Research Industry Survey, Areas of the Pharmaceutical Industry Artificial Intelligence Technologies are Currently Implemented In, Panel of Organizations Implementing Artificial Intelligence Solutions, 2018 39

Figure 11: Artificial Intelligence Technologies, GBI Research Industry Survey, Areas of the Healthcare Industry Artificial Intelligence Technologies are Currently Implemented In, Panel of Organizations Implementing Artificial Intelligence Solutions, 2018 40

Figure 12: Artificial Intelligence Technologies, GBI Research Industry Survey, Areas of the Pharmaceutical Industry Artificial Intelligence Technologies Will Demonstrate the Greatest Benefits, 2018 41

Figure 13: Artificial Intelligence Technologies, Representative Companies Deploying Artificial Intelligence in the Drug Discovery Space, 2018 43

Figure 14: Artificial Intelligence Technologies, Representative Companies Deploying Artificial Intelligence in the Clinical Trial Space, 2018 46

Figure 15: Artificial Intelligence Technologies, GBI Research Industry Survey, Areas of the Healthcare Industry Artificial Intelligence Technologies Will Serve the Greatest Benefit, 2018 51

Figure 16: Artificial Intelligence Technologies, Creating the Personalized Artificial Intelligence Approach to Healthcare Management, 2018 52

Figure 17: Artificial Intelligence Technologies, Co-development Deals by Company, 2018 (Part 1) 61

Figure 18: Artificial Intelligence Technologies, Co-development Deals by Company (Part 2), 2018 62

Figure 19: Artificial Intelligence Technologies, Co-development Deals by Company (Part 3), 2018 63

Figure 20: Artificial Intelligence Technologies, Licensing Deals by Company, 2018 64

Figure 21: Artificial Intelligence Technologies, GBI Industry Survey, Opinion of Surveyed Organizations on Which Area of Industry Will See the Greatest Positive Impact Following AI Investment, 2018–2023 80

Figure 22: Artificial Intelligence Technologies, GBI Industry Survey, Organizations Already Involved with Artificial Intelligence, Likelihood of Surveyed Organizations Increasing Investment in the Sector (%), 2018–2023 81

Figure 23: Artificial Intelligence Technologies, GBI Industry Survey, Organizations Already Involved with Artificial Intelligence, Likelihood of Surveyed Organizations Increasing Investment in the Sector (%), 2018–2023 82

Figure 24: Artificial Intelligence Technologies, GBI Industry Survey, Reasons Concerning Organizations when Investing in Artificial Intelligence Technology, 2018 83

Figure 25: Artificial Intelligence Technologies, GBI Industry Survey, Reasons Concerning Organizations when Investing in Artificial Intelligence Technology, 2018 84

Figure 26: Artificial Intelligence Technologies, GBI Industry Survey: Breakdown of Respondents by Industry, 2018 86

Figure 27: Artificial Intelligence, GBI Industry Survey: Breakdown of Respondents by Region, 2018 86

Figure 28: Artificial Intelligence Technologies, GBI Industry Survey: Proportion of Organizations that are Currently Involved with Artificial Intelligence Technologies, 2018 87

Figure 29: Artificial Intelligence Technologies, GBI Industry Survey: Most Important Factors Driving Growth in the Artificial Intelligence Market, 2018 87

Figure 30: Artificial Intelligence Technologies, GBI Industry Survey: Main Factors Restraining Growth in the Artificial Intelligence Market, 2018 88

Figure 31: Artificial Intelligence Technologies, GBI Industry Survey: Main Concerns for Organizations When Investing in Artificial Intelligence Technologies, 2018 88

Figure 32: Artificial Intelligence Technologies, GBI Industry Survey: Most Common Areas Where Artificial Intelligence Solutions are used in the Pharmaceutical Industry, 2018 89

Figure 33: Artificial Intelligence Technologies, GBI Industry Survey: Most Common Areas Where Artificial Intelligence Solutions are used in the Healthcare Industry, 2018 89

Figure 34: Artificial Intelligence Technologies, GBI Industry Survey: Areas of the Pharmaceutical Industry that will see the Greatest Benefits from Artificial Intelligence Implementation, 2018 90

Figure 35: Artificial Intelligence Technologies, GBI Industry Survey: Areas of the Healthcare Industry that will see the Greatest Benefit from Artificial Intelligence Implementation, 2018 90

Figure 36: Artificial Intelligence Technologies, GBI Industry Survey: Areas of the Healthcare Industry that will see the Greatest Benefit from Artificial Intelligence Implementation, 2018 91

Figure 37: Artificial Intelligence Technologies, GBI Industry Survey: Likelihood of Organizations Involved with AI Increasing Investments in the Sector (%) 2018–2023 91

Figure 38: Artificial Intelligence Technologies GBI Industry Survey: Likelihood of Organizations Involved with AI Increasing Investments in the Sector (%), 2018-2023 92

Figure 39: Artificial Intelligence Technologies, GBI Industry Survey: Main Concerns for Organizations When Investing in Artificial Intelligence Technologies, 2018 92

 

List of Tables

Table 1: Artificial Intelligence Technologies, Machine Learning in the Healthcare Industry, 2018 12

Table 2: Artificial intelligence Technologies, Examples of Artificial Intelligence Services Currently Available, 2018 16

Table 3: Artificial Intelligence Technologies, Johnson & Johnson Collaborations, 2018 66

Table 4: Artificial Intelligence Technologies, Roche Collaborations, 2018 67

Table 5: Artificial Intelligence Technologies, Pfizer Collaborations, 2018 67

Table 6: Artificial Intelligence Technologies, Novartis Collaborations, 2018 68

Table 7: Artificial Intelligence Technologies, Sanofi Collaborations, 2018 69

Table 8: Artificial Intelligence Technologies, List of AI Start-up Companies (Part 1), 2018 71

Table 9: Artificial Intelligence Technologies, List of Artificial Intelligence Start-up Companies (Part 2), 2018 73

Table 10: Artificial Intelligence Technologies, List of AI Start-up Companies (Part 3), 2018 75

Table 11: Artificial Intelligence Technologies, List of AI Start-up Companies (Part 4), 2018 77

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る